More information has emerged about “COVID arm” — a delayed arm rash appearing after Moderna’s COVID-19 vaccine is administered — including likelihood, duration and treatment. Researchers examined 16 ...
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, but only for specific populations: all adults 65 and over and those ...
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback